Sodium channel blocker. Prepn: R. Sachse, DE 2001431 (1971 to Helopharm), C.A. 75, 151538f (1971). Pharmacology: H.-J. Hapke, E. Prigge, Arzneim.-Forsch. 26, 1849 (1976). Pharmacokinetics: M. Hollmann et al., ibid. 33, 763 (1983). HPLC determn in plasma and urine: U. Hofmann et al., J. Chromatogr. B 748, 113 (2000). Review of pharmacology and therapeutic efficacy: H. M. Bryson et al., Drugs 45, 85-130 (1993). Review of clinical trials in supraventricular arrhythmias and atrial fibrillation: A. P. Rae, Am. J. Cardiol. 82, 59N-65N (1998); S. C. Reimold et al., ibid. 66N-71N.
Antiarrhythmic (class IC).
Antiarrhythmic